Screening or treatment? Both! 
Advances in screening and treatment are saving breast cancer patients’ lives. A recently published model-based analysis quantifies just how much of a difference these advances – seperately and combined – are making in reducing breast cancer mortality by molecular type.
The project was launched in September 2015 and will continue to August 2020.
This project has received funding from the European Unionʼs Horizon2020 Programme under grant agreement no 634753
